DavidE.LanfearMDMS

Heart Failure & Transplantation

Section Head, Advanced Heart Failure and Transplantation, Henry Ford Hospital Associate Professor, Internal Medicine, Wayne State University School of Medicine

Join to view full profile

Dr. Lanfear is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lanfear's full profile

Already have an account?

Office
Henry Ford Health System
2799 West Grand Boulevard
Detroit, MI 48202
Phone+1 313-916-9106

Fax+1 313-916-1249

Summary

Dr. David Lanfear is a cardiologist in Detroit, MI and is affiliated with Henry Ford Hospital. He received his medical degree from University of Michigan Medical School and has been in practice 19 years. He specializes in heart failure & transplantation and is experienced in echocardiography, cardiac critical care, heart failure and transplantation, vad management, and pharmacogenetics.

Education & Training

University of Michigan School of Public HealthMS, Biostatistics and Research Design, 2005 - 2007
Washington University/B-JH/SLCH ConsortiumFellowship, Cardiovascular Disease, 2001 - 2005
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1998 - 2001
University of Michigan Medical SchoolClass of 1998

Certifications & Licensure

MI State Medical License 2005 - 2027
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

Fellow (FAHA) American Heart Association, 2013
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Fellow (FACC) American College of Cardiology

Clinical Trials

INcrease Of VAgal TonE in CHF Start of enrollment: 2011 Feb 01
Terminated
Phase 3

Publications & Presentations

PubMed

Guideline-Directed Medical Therapy After Hospitalization for Acute Heart Failure: Insights From the CONNECT-HF.
Satoshi Shoji, Lisa Kaltenbach, Bradi B Granger, Gregg C Fonarow, Hussein R Al-Khalidi
Journal of the American Heart Association. 2024-12-10
Metabolic Effects of the SGLT2 Inhibitor Dapagliflozin in Heart Failure Across the Spectrum of Ejection Fraction.
Senthil Selvaraj, Shachi Patel, Andrew J Sauer, Robert W McGarrah, Philip Jones
Circulation. Heart Failure. 2024-11-01
Equal Treatment, Unequal Outcomes? Debunking the Racial Disparity in Renin Angiotensin Aldosterone System Inhibitor Associated Reduction in Heart Failure Hospitalizati...
Shana D R Littleton, David E Lanfear, Michael P Dorsch, Bin Liu, Jasmine A Luzum
Journal of Cardiac Failure. 2024-10-21

Journal Articles

Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure
John R Teerlink, David E Lanfear, Thomas M Suter, Narimon Honarpour, Siddique A Abbasi, Fady I Malik, Christopher E Kurtz, The New England Journal of Medicine
Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome
David E Lanfear 1, Philip G Jones, Sharon Marsh, Sharon Cresci, Howard L McLeod, John A Spertus, JAMA, 9/28/2005

Lectures

Non-Invasive Markers for Precision Medicine in Transplant Emerging Science Coming to the Clinic
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
Best Practices in Hear Failure: 'How to' With the Experts
2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019

Authored Content

Cardiopulmonary Exercise Measures of Men and Women with Hfref Differ in Their Relationship to Prognosis: The Henry Ford Hospital Cardiopulmonary Exercise Testing (Fit-CPX) ProjectFebruary 2018
Cardiopulmonary Exercise Measures of Men and Women with Hfref Differ in Their Relationship to Prognosis: The Henry Ford Hospital Cardiopulmonary Exercise Testing (Fit-CPX) ProjectFebruary 2018

Press Mentions

Put It on the BoardMay 18th, 2023
Illumina Taps Henry Ford Health System to Explore Whole-Genome Testing for Heart DiseaseApril 17th, 2023
Illumina, Henry Ford Health Partner to Study Impact of CGP on Cardiovascular DiseaseApril 11th, 2023
Join now to see all

Grant Support

Impact Of RACE And Genetic Factors On Beta-Blocker Effectiveness In Heart FailureNational Heart, Lung, And Blood Institute2011–2012
Pharmacogenetics Of The B-Type Natriuretic Peptide PathwayNational Heart, Lung, And Blood Institute2008–2011